CoChat

Cardiac Autonomic Neuropathy and Early Progressive Renal Decline in Patients with Nonmacroalbuminuric Type 1 Diabetes

Open access
Orlov, Steven, Cherney, David Z.I., Pop-Busui, Rodica, Lovblom, Leif E., Ficociello, Linda H., Smiles, Adam M., Warram, James H., Krolewski, Andrzej S., Perkins, Bruce A. · 2015 · Clinical Journal of the American Society of Nephrology

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND OBJECTIVES: Cardiac autonomic neuropathy predicts future adverse renal outcomes in the general population. This study sought to determine its relationship with early progressive renal decline in type 1 diabetes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A subset of participants with normoalbuminuria (n=204) or microalbuminuria (n=166) from the First Joslin Kidney Study underwent assessment for cardiac autonomic neuropathy using heart rate variability during baseline visits performed from January 1991 to April 1992. Cardiac autonomic neuropathy was defined as an R-R variation (mean circular resultant) <20. Participants also had baseline and follow-up measurement of eGFR. Early progressive renal decline was evaluated according to two definitions: early GFR loss (slope of eGFR estimated by cystatin C <-3.3%/year) and incident advanced CKD (stage ≥3, defined by eGFR [calculated by Modification of Diet in Renal Disease method] <60 ml/min per 1.73 m(2)). Association with baseline cardiac autonomic neuropathy was assessed by adjusted logistic regression and Cox proportional hazards. RESULTS: Among the 370 participants, 47 (13%) had baseline cardiac autonomic neuropathy, 51 (14%) had early GFR loss, and 68 (18%) had incident advanced CKD over a median 14-year follow-up. Early GFR loss occurred in 15 (32%) of the 47 patients with baseline autonomic neuropathy and in 32 (10%) of the 323 without baseline autonomic neuropathy (P<0.001). Baseline autonomic neuropathy was strongly associated with odds of early GFR loss (adjusted odds ratio, 4.09; 95% confidence interval, 1.65 to 10.12; P=0.002). Incident advanced CKD was observed in 22 (47%) of those with baseline autonomic neuropathy and 46 (14%) of those without baseline autonomic neuropathy (P<0.001). Autonomic neuropathy was independently associated with incident advanced CKD (adjusted hazard ratio, 2.76; 95% confidence interval, 1.44 to 5.30; P=0.002). CONCLUSIONS: Cardiac autonomic neuropathy was a strong independent predictor of the long-term risk of early progressive renal decline in type 1 diabetes. Future research should explore the mechanisms by which autonomic neuropathy may be associated with renal function loss.

Overview

Integrity signals

Registry

Crossref · 10.2215/cjn.11441114

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Low, 1997, Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects., Muscle Nerve, 20, 1561, 10.1002/(SICI)1097-4598(199712)20:12<1561::AID-MUS11>3.0.CO;2-3 · doi:10.1002/(sici)1097-4598(199712)20:12<1561::aid-mus11>3.0.co;2-3

Cited by

See all 57

Metadata

Authors
Orlov, S., Cherney, D. Z. I., Pop-Busui, R., Lovblom, L. E., Ficociello, L. H., Smiles, A. M., Warram, J. H., Krolewski, A. S., & Perkins, B. A.
Affiliations
  • Mount Sinai Hospital (CA)
  • University of Toronto (CA)
  • Joslin Diabetes Center (US)
Corresponding author
  • Orlov, Steven
  • Lovblom, Leif E.
  • Perkins, Bruce A.
Venue
Clinical Journal of the American Society of Nephrology
Published
2015-07
Volume
10
Issue
7
Pages
1136-1144
ISSN
1555-9041 (ISSN-L)
OpenAlex
W2401113515
Cited by
57
References
50
Citations by year
2026: 3 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 8 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 6 · 2017: 1 · 2016: 5 · 2015: 1
FWCI
3.76
Type
journal article
Language
en
Open access
Locations
  • Clinical Journal of the American Society of Nephrology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Toronto
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-41526, R01DK041526, P30DK020572)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Keywords
neuropathy, type 1 diabetes, diabetic nephropathy, heart rate variability, microalbuminuria, normoalbuminuria, chronic kidney disease progression, estimated glomerular filtration rate decline, cystatin C, cardiovascular risk stratification
MeSH terms
Adolescent, Adult, Autonomic Nervous System, Boston, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Diabetic Neuropathies, Female, Follow-Up Studies, Glomerular Filtration Rate, Heart, Heart Rate, Humans, Kidney, Male, Prospective Studies, Risk Factors, Time Factors, Biomarkers, Incidence, Multivariate Analysis, Logistic Models, Proportional Hazards Models, Odds Ratio, Disease Progression, Cystatin C, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.